Sunrest Lifescience (NSE:SUNREST) Net Margin %: 9.19% (As of Mar. 2026) — 191% Above Median


NSE:SUNREST Sunrest Lifescience Ltd NSE:SUNREST
41 GF Score
Price ₹35.05
! 5 Warning Signs
View Full Analysis

What is Sunrest Lifescience Net Margin %?

Sunrest Lifescience NSE:SUNREST 41 Net Margin % is 9.19% as of Mar. 2026, which is 191% above its 10-year median of 3.16. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Sunrest Lifescience ranks better than 75.6% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Sunrest Lifescience's Net Income for the six months ended in Mar. 2026 was ₹33.8 Mil. Sunrest Lifescience's Revenue for the six months ended in Mar. 2026 was ₹368.2 Mil. Therefore, Sunrest Lifescience's net margin for the quarter that ended in Mar. 2026 was 9.19%.

The historical rank and industry rank for Sunrest Lifescience's Net Margin % or its related term are showing as below:

NSE:SUNREST' s Net Margin % Range Over the Past 10 Years
Min: 0.35   Med: 3.16   Max: 9.19
Current: 9.19


NSE:SUNREST's Net Margin % is ranked better than
75.6% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 2.885 vs NSE:SUNREST: 9.19

Sunrest Lifescience  (NSE:SUNREST) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sunrest Lifescience Net Margin % Related Terms


Sunrest Lifescience Net Margin % Historical Data

* Premium members only.

The historical data trend for Sunrest Lifescience's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience Net Margin % Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial 3.16 8.50 0.77 6.00 5.81

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only 15.92 -10.35 3.78 7.90 9.19

Sunrest Lifescience Net Margin % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunrest Lifescience Net Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sunrest Lifescience's Net Margin % falls into.


NSE:SUNREST
41GF Score
Sunrest Lifescience Ltd NSE:SUNREST
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunrest Lifescience Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sunrest Lifescience's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=41.163/708.329
=5.81 %

Sunrest Lifescience's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=33.828/368.224
=9.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 9.19% mean?
Sunrest Lifescience (NSE:SUNREST) has a Net Margin % of 9.19% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Sunrest Lifescience and its competitors. This is 191% above median its historical median of 3.16. Over the past decade, Sunrest Lifescience's Net Margin % has ranged from 0.35 to 9.19. According to the industry distribution chart, Sunrest Lifescience ranks #163 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 24.4%.
Is Sunrest Lifescience's Net Margin % too high?
Sunrest Lifescience's current Net Margin % of 9.19% is 191% above median its 10-year median of 3.16. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 9.19. The Healthcare Providers & Services industry median Net Margin % is 2.89. Sunrest Lifescience's value of 9.19% is 218.5% above this industry median. Based on the distribution chart, Sunrest Lifescience ranks #163 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #163 out of 668 companies for Net Margin %. This places Sunrest Lifescience in the top 24% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. Sunrest Lifescience's value of 9.19% is 218.5% above this benchmark. Historically, Sunrest Lifescience's own Net Margin % has ranged from 0.35 to 9.19 over the past decade. While the company's 10-year median is 3.16 vs. the industry median of 2.89, Sunrest Lifescience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current Net Margin % of 9.19% is 218.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current Net Margin % is 9.19%, which is 191% above median its own 10-year median of 3.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Net Margin % of 9.19%. The current Net Margin % is 9.19%, which is 191% above median its 10-year median of 3.16 and 218.5% above the Healthcare Providers & Services industry median of 2.89. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Net Margin % is 9.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunrest Lifescience Business Description

Address YMCA Club, Near SG Highway, D-608 West Gate, Near Brooklin Tower, Makarba, Jivraj Park, Ahmedabad, GJ, IND, 380051
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score

Get the complete analysis for NSE:SUNREST

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.05
Price